The use of roxithromycin in the treatment of acute bacterial rhinosinusitis

According to epidemiological studies, bacterial rhinosinusitis is one of the most common pathologies of ENT-organs on an upward trend. Rhinosinusitis significantly reduces the patient’s quality of life and, in the absence of timely treatment, can lead to serious complications. Macrolide antibiotics...

Full description

Bibliographic Details
Main Authors: A. A. Krivopalov, A. Р. Smirnov
Format: Article
Language:Russian
Published: Remedium Group LLC 2019-01-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/2817
_version_ 1797841833008562176
author A. A. Krivopalov
A. Р. Smirnov
author_facet A. A. Krivopalov
A. Р. Smirnov
author_sort A. A. Krivopalov
collection DOAJ
description According to epidemiological studies, bacterial rhinosinusitis is one of the most common pathologies of ENT-organs on an upward trend. Rhinosinusitis significantly reduces the patient’s quality of life and, in the absence of timely treatment, can lead to serious complications. Macrolide antibiotics are effective drugs in the treatment of rhinosinusitis. Roxithromycin (Esparoxy), one of modern macrolides, showed good results. The article provides characteristics of this drug, reflects the high quality of efficacy and safety in the treatment of bacterial rhinosinusitis, with due regard to the experience of the Russian and foreign authors.
first_indexed 2024-04-09T16:37:35Z
format Article
id doaj.art-5421e67efe5344bc958a728156012bb8
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:37:35Z
publishDate 2019-01-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-5421e67efe5344bc958a728156012bb82023-04-23T06:56:49ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902019-01-01021616510.21518/2079-701X-2018-21-61-652751The use of roxithromycin in the treatment of acute bacterial rhinosinusitisA. A. Krivopalov0A. Р. Smirnov1Federal State Budgetary Institution of Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Healthcare of the Russian FederationFederal State Budgetary Institution of Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Healthcare of the Russian FederationAccording to epidemiological studies, bacterial rhinosinusitis is one of the most common pathologies of ENT-organs on an upward trend. Rhinosinusitis significantly reduces the patient’s quality of life and, in the absence of timely treatment, can lead to serious complications. Macrolide antibiotics are effective drugs in the treatment of rhinosinusitis. Roxithromycin (Esparoxy), one of modern macrolides, showed good results. The article provides characteristics of this drug, reflects the high quality of efficacy and safety in the treatment of bacterial rhinosinusitis, with due regard to the experience of the Russian and foreign authors.https://www.med-sovet.pro/jour/article/view/2817bacterial rhinosinusitisantibacterial therapyroxithromycinesparoxy®
spellingShingle A. A. Krivopalov
A. Р. Smirnov
The use of roxithromycin in the treatment of acute bacterial rhinosinusitis
Медицинский совет
bacterial rhinosinusitis
antibacterial therapy
roxithromycin
esparoxy®
title The use of roxithromycin in the treatment of acute bacterial rhinosinusitis
title_full The use of roxithromycin in the treatment of acute bacterial rhinosinusitis
title_fullStr The use of roxithromycin in the treatment of acute bacterial rhinosinusitis
title_full_unstemmed The use of roxithromycin in the treatment of acute bacterial rhinosinusitis
title_short The use of roxithromycin in the treatment of acute bacterial rhinosinusitis
title_sort use of roxithromycin in the treatment of acute bacterial rhinosinusitis
topic bacterial rhinosinusitis
antibacterial therapy
roxithromycin
esparoxy®
url https://www.med-sovet.pro/jour/article/view/2817
work_keys_str_mv AT aakrivopalov theuseofroxithromycininthetreatmentofacutebacterialrhinosinusitis
AT arsmirnov theuseofroxithromycininthetreatmentofacutebacterialrhinosinusitis
AT aakrivopalov useofroxithromycininthetreatmentofacutebacterialrhinosinusitis
AT arsmirnov useofroxithromycininthetreatmentofacutebacterialrhinosinusitis